{"id":"W2134683286","doi":"10.1111/j.1538-7836.2012.04693.x","title":"A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer","year":2012,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":190,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; Montreal General Hospital; McMaster University; Ontario Clinical Oncology Group","funders":"","keywords":"Apixaban; Medicine; Internal medicine; Placebo; Chemotherapy; Cancer; Adverse effect; Population; Randomized controlled trial; Surgery; Warfarin; Atrial fibrillation; Rivaroxaban","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001974746,0.002112786,0.00392599,0.0004968468,0.0005854177,0.001702429,0.001105346,0.002094563,0.007699468],"category_scores_gemma":[0.003073747,0.0009233236,0.002233558,0.0005270163,0.001432708,0.001461611,0.0005153281,0.004917657,0.001247595],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000785858,"about_ca_system_score_gemma":0.001362326,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001010525,"about_ca_topic_score_gemma":0.001918755,"domain_scores_codex":[0.9991835,0.0004680812,0.00004740206,0.0001483813,0.00005508214,0.00009757747],"domain_scores_gemma":[0.9987661,0.0004014427,0.0002493477,0.0001422164,0.00006929256,0.000371645],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9830284,0.003123038,0.0004890978,0.0004480196,0.001179787,0.00004563887,0.0000382444,0.0002683414,0.001355791,0.0001330793,0.0009063559,0.008984209],"study_design_scores_gemma":[0.9834182,0.0149589,0.0006111978,0.00001376854,0.0002882603,0.00002986884,0.000012503,0.0001691414,0.0001027093,0.00009479416,0.0002936,0.000007047081],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9740466,0.01000685,0.001319902,0.002570796,0.001776323,0.004991669,0.001610189,0.0002292154,0.003448552],"genre_scores_gemma":[0.9792221,0.00502935,0.002176866,0.002392615,0.0009074785,0.004818422,0.00177776,0.0000527654,0.003622503],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007699468,"threshold_uncertainty_score":0.02575725,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06639380112779261,"score_gpt":0.37552157031707,"score_spread":0.3091277691892773,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}